These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4152695)

  • 1. [Longitudinal studies on the metabolite pattern of perazine and related phenothiazines in human and animal].
    Breyer U
    Arzneimittelforschung; 1974 Jul; 24(7):989-90. PubMed ID: 4152695
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metabolism of oxaflumazine].
    Boissier JR; Gérardin A; Dumont C
    Ann Pharm Fr; 1972 Dec; 30(12):851-60. PubMed ID: 4148298
    [No Abstract]   [Full Text] [Related]  

  • 3. Tissue accumulation of metabolites during chronic administration of piperazine-substituted phenothiazine drugs.
    Breyer U; Gaertner HJ
    Adv Biochem Psychopharmacol; 1974; 9(0):167-73. PubMed ID: 4151761
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo piperazine ring degradation in neuroleptic and antihistaminic drugs.
    Gaertner HJ; Breyer U
    Arzneimittelforschung; 1972 Jun; 22(6):1084-5. PubMed ID: 4403218
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic fate of the antipsychotic agent, mazapertine, in man--API-MS and MS/MS identification of urinary metabolites.
    Wu WN; McKown LA; Reitz AB
    Eur J Drug Metab Pharmacokinet; 2007; 32(3):171-6. PubMed ID: 18062409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photo-decomposition and metabolism of the phenothiazine drug perazine.
    Schley J
    Arzneimittelforschung; 1986 Apr; 36(4):635-7. PubMed ID: 2872901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radiochromatographic studies of excretion and metabolism of methophenazine (Frenolon) in animal experiments].
    Jászsági-Nagy E; Elekes I
    Pharmazie; 1969 Jun; 24(6):337-8. PubMed ID: 5807396
    [No Abstract]   [Full Text] [Related]  

  • 8. Study of the metabolism of phenothiazines: determination of N-demethylated phenothiazines in urine.
    Choo HY; Shin YO; Park J
    J Anal Toxicol; 1990; 14(2):116-9. PubMed ID: 1969973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolism of the piperazine-type phenothiazine neuroleptic perazine by the human cytochrome P-450 isoenzymes.
    Wójcikowski J; Pichard-Garcia L; Maurel P; Daniel WA
    Eur Neuropsychopharmacol; 2004 May; 14(3):199-208. PubMed ID: 15056479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of phenothiazine neuroleptics after chronic coadministration of carbamazepine.
    Daniel WA; Syrek M; Haduch A; Wójcikowski J
    Pol J Pharmacol; 1998; 50(6):431-42. PubMed ID: 10385926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary metabolites of 10-(3'-(4"-methyl-piperazinyl)-propyl)-phenothiazine (perazine) in psychiatric patients. II. Individual metabolite patterns and their changes in the course of treatment.
    Kanig K; Breyer U
    Psychopharmacologia; 1969; 14(3):211-20. PubMed ID: 5351861
    [No Abstract]   [Full Text] [Related]  

  • 12. Distribution and metabolism of the antipsychotic agent mazapertine succinate in rats.
    Caldwell GW; Wu WN; McKown LA; Diane Gauthier A; Masucci JA; Jones WJ; Leo GC; Reitz AB
    J Pharm Biomed Anal; 2006 May; 41(2):500-9. PubMed ID: 16386397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a urinary metabolite of perazine as a piperazine-2,5-dione derivative.
    Krauss D; Otting W; Breyer U
    J Pharm Pharmacol; 1969 Dec; 21(12):808-13. PubMed ID: 4391052
    [No Abstract]   [Full Text] [Related]  

  • 14. [Metabolism and excretion of the neuroleptic drug perazine in healthy volunteers].
    Schley J; Riedel E; Müller-Oerlinghausen B
    Int Pharmacopsychiatry; 1981; 16(4):201-11. PubMed ID: 6121765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings: Effect of chronic treatment with perazine (Taxilan-R) on the pharmacokinetic behaviour of phenazone in man.
    Schüppel RV; Petruch F
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R90. PubMed ID: 238154
    [No Abstract]   [Full Text] [Related]  

  • 16. [Binding of perazine metabolites and phenothiazine derivatives to acid alpha 1-glycoprotein].
    Schley J
    Arzneimittelforschung; 1983; 33(2):185-7. PubMed ID: 6133521
    [No Abstract]   [Full Text] [Related]  

  • 17. High affinity binding of perazine and desmethylperazine to human alpha 1-acid glycoprotein.
    Schley J; Nündel M; Siegert M; Riedel E; Müller-Oerlinghausen B
    Pharmakopsychiatr Neuropsychopharmakol; 1980 May; 13(3):144-5. PubMed ID: 6104826
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of rat liver CYP2D in vitro and after 1-day and long-term exposure to neuroleptics in vivo-possible involvement of different mechanisms.
    Daniel WA; Haduch A; Wójcikowski J
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):103-10. PubMed ID: 15572279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gas chromatographic method for the quantitative determination of ftoratsizin and its N-dealkylated metabolites in animal and human biological material].
    Zherdev VP; Ekonomov AL; Vikhliaev IuI
    Farmakol Toksikol; 1980; 43(2):215-8. PubMed ID: 6108236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A cyamepromazine-trifluoperazine combination: changes in metabolism during chronic administration in the rat].
    Gaillot J; Bieder A; Ghaye Roquet J; Le Liboux A; Mazeau L
    Therapie; 1975; 30(2):267-76. PubMed ID: 240218
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.